A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

Respicardia’s remedē Implantable Device for the Treatment of Central Sleep Apnea

Respicardia, Inc. (formerly Cardiac Concepts, Inc.) is a privately held medical device company incorporated in 2006. It is located in Minneapolis, Minnesota, USA.  It is developing an implantable system intended to improve the outcomes for Heart Failure patients by developing an implantable stimulation therapy to treat Central Sleep Apnea. The remedē System is an implantable

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Respicardia’s remedē Implantable Device for the Treatment of Central Sleep Apnea  comments 
formats

ImThera Medical’s Aura6000 Implantable System for the Treatment of Sleep Apnea

The aura6000 is based on ImThera’s Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy™ delivering neurostimulation to the tongue during sleep. The system is comprised of a surgically‐placed multi‐contact electrode specifically designed for the Hypoglossal nerve, and a lead that connects the electrode to a programmable implantable pulse generator (IPG) that is placed in the anterior chest wall.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on ImThera Medical’s Aura6000 Implantable System for the Treatment of Sleep Apnea  comments 
formats

Apnex Medical’s Implantable Device for Treatment of Sleep Apnea

MedicalApnex Medical, Inc. is located in St. Paul, MN. It was founded in 2006 and has developed the Hypoglossal Nerve Stimulation System (HGNS® System) for the treatment of obstructive sleep apnea (OSA). The HGNS System has been evaluated in feasibility studies and is now being assessed in an Investigational Device Exemption (IDE) Study (Apnex®Clinical Study).

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Apnex Medical’s Implantable Device for Treatment of Sleep Apnea  comments 
formats

Inspire Medical’s IPG for the Treatment of Sleep Apnea

Inspire Medical Systems, based in Minneapolis, Minnesota, develops implantable neurostimulation systems to treat Obstructive Sleep Apnea (OSA).  Inspire Medical Systems was formed when the Inspire intellectual property and technology was licensed and spun out from Medtronic in 2007. Inspire therapy is designed to deliver physiologically-timed, mild stimulation to the hypoglossal nerve on each breathing cycle

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Inspire Medical’s IPG for the Treatment of Sleep Apnea  comments